Literature DB >> 18322959

Gastric motor effects of ghrelin and growth hormone releasing peptide 6 in diabetic mice with gastroparesis.

Wen-Cai Qiu1, Zhi-Gang Wang, Wei-Gang Wang, Jun Yan, Qi Zheng.   

Abstract

AIM: To investigate the potential therapeutic significance of ghrelin and growth hormone releasing peptide 6 (GHRP-6) in diabetic mice with gastric motility disorders.
METHODS: A diabetic mouse model was established by intraperitoneal (ip) injection of alloxan. Diabetic mice were injected ip with ghrelin or GHRP-6 (20-200 microg/kg), and the effects on gastric emptying were measured after intragastric application of phenol red. The effect of atropine, NG-nitro-L-arginine methyl ester hydrochloride (L-NAME) or D-Lys3-GHRP-6 (a growth hormone secretagogue receptor (GHS-R) antagonist) on the gastroprokinetic effect of ghrelin or GHRP-6 (100 microg/kg) was also investigated. The effects of ghrelin or GHRP-6 (0.01-10 micromol/L) on spontaneous or carbachol-induced contractile amplitude were also investigated in vitro, in gastric fundic circular strips taken from diabetic mice. The presence of growth hormone secretagogue receptor 1a transcripts in the fundic strips of diabetic mice was detected by reverse transcriptase polymerase chain reaction (RT-PCR).
RESULTS: We established a diabetic mouse model with delayed gastric emptying. Ghrelin and GHRP-6 accelerated gastric emptying in diabetic mice with gastroparesis. In the presence of atropine or L-NAME, which delayed gastric emptying, ghrelin and GHRP-6 (100 microg/kg) failed to accelerate gastric emptying. D-Lys3-GHRP-6 also delayed gastric emptying induced by the GHS-R agonist. Ghrelin and GHRP-6 increased the carbachol-induced contractile amplitude in gastric fundic strips taken from diabetic mice. RT-PCR confirmed the presence of GHS-R mRNA in the strip preparations.
CONCLUSION: Ghrelin and GHRP-6 increase gastric emptying in diabetic mice with gastroparesis, perhaps by activating peripheral cholinergic pathways in the enteric nervous system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322959      PMCID: PMC2693693          DOI: 10.3748/wjg.14.1419

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.

Authors:  C D R Murray; N M Martin; M Patterson; S A Taylor; M A Ghatei; M A Kamm; C Johnston; S R Bloom; A V Emmanuel
Journal:  Gut       Date:  2005-08-05       Impact factor: 23.059

2.  A role for ghrelin in the central regulation of feeding.

Authors:  M Nakazato; N Murakami; Y Date; M Kojima; H Matsuo; K Kangawa; S Matsukura
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

3.  Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro.

Authors:  T Kitazawa; B De Smet; K Verbeke; I Depoortere; T L Peeters
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

4.  A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.

Authors:  D Patterson; T Abell; R Rothstein; K Koch; J Barnett
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

5.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.

Authors:  Y Date; M Kojima; H Hosoda; A Sawaguchi; M S Mondal; T Suganuma; S Matsukura; K Kangawa; M Nakazato
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

6.  Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro.

Authors:  Inge Depoortere; Benedicte De Winter; Theo Thijs; Joris De Man; Paul Pelckmans; Theo Peeters
Journal:  Eur J Pharmacol       Date:  2005-05-16       Impact factor: 4.432

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.

Authors:  J Tack; I Depoortere; R Bisschops; K Verbeke; J Janssens; T Peeters
Journal:  Aliment Pharmacol Ther       Date:  2005-11-01       Impact factor: 8.171

9.  A receptor in pituitary and hypothalamus that functions in growth hormone release.

Authors:  A D Howard; S D Feighner; D F Cully; J P Arena; P A Liberator; C I Rosenblum; M Hamelin; D L Hreniuk; O C Palyha; J Anderson; P S Paress; C Diaz; M Chou; K K Liu; K K McKee; S S Pong; L Y Chaung; A Elbrecht; M Dashkevicz; R Heavens; M Rigby; D J Sirinathsinghji; D C Dean; D G Melillo; A A Patchett; R Nargund; P R Griffin; J A DeMartino; S K Gupta; J M Schaeffer; R G Smith; L H Van der Ploeg
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

10.  Evidence for the presence of motilin, ghrelin, and the motilin and ghrelin receptor in neurons of the myenteric plexus.

Authors:  Luo Xu; Inge Depoortere; Catherine Tomasetto; Michèle Zandecki; Ming Tang; Jean-Pierre Timmermans; Theo L Peeters
Journal:  Regul Pept       Date:  2005-01-15
View more
  13 in total

Review 1.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Therapeutic applications of ghrelin agonists in the treatment of gastroparesis.

Authors:  Andrea Shin; John M Wo
Journal:  Curr Gastroenterol Rep       Date:  2015-02

3.  Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease.

Authors:  Miwa Nahata; Shuichi Muto; Nobuhiko Oridate; Shunsuke Ohnishi; Koji Nakagawa; Chiharu Sadakane; Yayoi Saegusa; Tomohisa Hattori; Masahiro Asaka; Hiroshi Takeda
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-19       Impact factor: 4.052

4.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

5.  The prokinetic face of ghrelin.

Authors:  Hanaa S Sallam; Jiande D Z Chen
Journal:  Int J Pept       Date:  2010-02-10

6.  Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying.

Authors:  Igor A Harsch; Corinna Koebnick; Atingwa M Tasi; Eckhart Georg Hahn; Peter C Konturek
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

7.  ER stress and ER stress-induced apoptosis are activated in gastric SMCs in diabetic rats.

Authors:  Xia Chen; Xiang-Sheng Fu; Chang-Ping Li; Hong-Xian Zhao
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 8.  Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.

Authors:  Michael Camilleri; Athanasios Papathanasopoulos; Suwebatu T Odunsi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06       Impact factor: 46.802

9.  Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice.

Authors:  Qi Zheng; Wen-Cai Qiu; Jun Yan; Wei-Gang Wang; Song Yu; Zhi-Gang Wang; Kai-Xing Ai
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

10.  Gastric mucosal damage in water immersion stress: mechanism and prevention with GHRP-6.

Authors:  Shu Guo; Qian Gao; Qing Jiao; Wei Hao; Xue Gao; Ji-Min Cao
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.